Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
clinical trials
fda
life sciences
national blog main
san diego blog main
2
×
san diego top stories
achaogen
adams street partners
antibiotics
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
biotech ipos
boston
boston blog main
boston top stories
deals
drug resistance
drugs
dyne therapeutics
hatteras venture partners
investing
lyzz capital
macrolide pharmaceuticals
melinta therapeutics
meropenem
metacrine
michael dudley
myotonic dystrophy type 1
new enterprise associates
new york blog main
nonalcoholic steatohepatitis
rare disease drugs
rare diseases
rempex pharmaceuticals
salk institute
san diego
spero therapeutics
stanford university draper fund
startups
What
company
2
×
drug
medicines
therapeutics
2
×
bacteria
biopharma
brings
business
developing
disease
disorders
dyne
dyne’s
exited
fighting
genetic
infections
infectious
ipo
launches
melinta
million
muscle
muscular
preclinical
products
qpex
raised
rare
resistant
sold
stage
tackle
topped
upsized
year
Language
unset
Current search:
therapeutics
×
company
×
biotech
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections